Skip to content
Methodology
All entries for: Immusoft CA Inc.
October 16, 2025
Immusoft CA Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of mucopolysaccharidosis type II
Disease Area:
Rare Diseases
Source
Scroll to Top
